|
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Browse
Merck & Co., Inc.: PharmaVitae Profile
This analysis examines the historical and forecast performance for Merck & Co. in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 yea
Forest Laboratories Inc.: PharmaVitae Profile
This analysis examines the historical and forecast performance for Forest in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal
Shire plc: PharmaVitae Profile
This analysis examines the historical and forecast performance for Shire in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sale
Bayer Schering Pharma AG: PharmaVitae Profile 2007
This analysis examines the historical and forecast performance for Bayer Schering in the ethical pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal
Mitsubishi Tanabe Pharma Corporation: PharmaVitae Profile
This analysis examines the historical and forecast performance for Mitsubishi Tanabe in the ethical pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year
Solvay: PharmaVitae Profile
This analysis examines the historical and forecast performance for Solvay in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal
Eli Lilly & Co.: PharmaVitae Profile 2006
This analysis examines the historical and forecast performance for Eli Lilly in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year
Les Laboratoires Servier: PharmaVitae Profile 2007
This analysis examines the historical and forecast performance for Servier in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa
Takeda Pharmaceutical Co., Ltd: PharmaVitae Profile
This analysis examines the historical and forecast performance for Takeda in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal
Cephalon Inc.: PharmaVitae Profile
This analysis examines the historical and forecast performance for Cephalon in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year s
Astellas Pharma Inc.: PharmaVitae Profile
This analysis examines the historical and forecast performance for Shionogi in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year s
Watson: PharmaVitae Generics Profile
This analysis examines the historical and forecast performance for Watson in the generic pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal
Almirall: PharmaVitae Profile
This analysis examines the historical and forecast performance for Almirall in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year s
Abbott Laboratories: PharmaVitae Profile 2007
This analysis examines the historical and forecast performance for Abbott in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal
Solvay S.A.: PharmaVitae Profile 2007
This analysis examines the historical and forecast performance for Solvayin the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sale
Merck KGaA: PharmaVitae Profile
Analysis of Merck KGaA’s corporate strategy, marketed portfolio, pipeline potential and financial position in 2007 and to 2013
Genzyme Corporation: PharmaVitae Profile 2007
This analysis examines the historical and forecast performance for Genzyme in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa
Allergan Inc.: PharmaVitae Profile
This analysis examines the historical and forecast performance for Allergan in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year s
Eisai Co., Ltd: PharmaVitae Profile
This analysis examines the historical and forecast performance for Eisai in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sale
|
